Vaccines for COVID‐19 | Zendy

Tregoning J. S. | Zendy; Brown E. S. | Zendy; Cheeseman H. M. | Zendy; Flight K. E. | Zendy; Higham S. L. | Zendy; Lemm N.M. | Zendy; Pierce B. F. | Zendy; Stirling D. C. | Zendy; Wang Z. | Zendy; Pollock K. M. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Vaccines for COVID‐19

Author(s) -

Tregoning J. S.,

Brown E. S.,

Cheeseman H. M.,

Flight K. E.,

Higham S. L.,

Lemm N.M.,

Pierce B. F.,

Stirling D. C.,

Wang Z.,

Pollock K. M.

Publication year - 2020

Publication title -

clinical & experimental immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.329

H-Index - 135

eISSN - 1365-2249

pISSN - 0009-9104

DOI - 10.1111/cei.13517

Subject(s) - pandemic , covid-19 , outbreak , medicine , population , clinical trial , intensive care medicine , virology , environmental health , disease , infectious disease (medical specialty) , pathology

The spread of the virus SARS‐CoV‐2, the cause of COVID‐19 has triggered a tidal wave of vaccine development. In the first 9 months since the virus emerged over 200 vaccines have begun pre‐clinical development, 36 of which have entered clinical trials. This review will cover the platforms under assessment, the immune responses underpinning the vaccines, the results so far and the considerations for the next steps.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research